Arcutis Biotherapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 02/17/2026 | 11.96 M | $347.43 M | 14.18% | 9.37% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/13/2026 | 9.87 M | $286.76 M | 0.00% | 7.74% |
| BLACKROCK, INC. | 02/12/2026 | 9.10 M | $264.25 M | 6.13% | 7.13% |
| RUBRIC CAPITAL MANAGEMENT LP | 02/13/2026 | 8.27 M | $240.21 M | -23.05% | 6.48% |
| VANGUARD GROUP INC | 01/29/2026 | 7.25 M | $210.65 M | 1.51% | 5.68% |
| JENNISON ASSOCIATES LLC | 01/30/2026 | 6.76 M | $196.25 M | -44.85% | 5.30% |
| POLAR CAPITAL HOLDINGS PLC | 02/17/2026 | 5.56 M | $161.35 M | 4.86% | 4.35% |
| STATE STREET CORP | 02/13/2026 | 5.49 M | $159.38 M | 18.25% | 4.30% |
| GILDER GAGNON HOWE & CO LLC | 02/17/2026 | 4.45 M | $129.34 M | 0.56% | 3.49% |
| MORGAN STANLEY | 02/13/2026 | 4.34 M | $126.04 M | 1.49% | 3.40% |
| UBS GROUP AG | 01/29/2026 | 3.24 M | $94.19 M | 10.01% | 2.54% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 2.75 M | $79.97 M | 5.63% | 2.16% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 2.68 M | $77.92 M | 26.64% | 2.10% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/17/2026 | 2.56 M | $74.41 M | 133.59% | 2.01% |
| ENSIGN PEAK ADVISORS, INC | 02/12/2026 | 1.90 M | $55.25 M | -4.55% | 1.49% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 1.90 M | $55.18 M | -17.78% | 1.49% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 1.83 M | $53.15 M | -23.68% | 1.43% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.67 M | $48.60 M | 88.18% | 1.31% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 1.58 M | $45.78 M | -12.66% | 1.24% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 1.47 M | $42.61 M | -11.75% | 1.15% |
| NUVEEN, LLC | 02/12/2026 | 1.38 M | $40.14 M | 0.86% | 1.08% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 02/13/2026 | 1.37 M | $39.69 M | -35.55% | 1.07% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 1.17 M | $33.87 M | 1,228.38% | 0.91% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 1.01 M | $29.47 M | 1.54% | 0.80% |
| GW&K INVESTMENT MANAGEMENT, LLC | 02/11/2026 | 1.01 M | $29.29 M | -13.95% | 0.79% |
| NORTHERN TRUST CORP | 02/17/2026 | 955.24 K | $27.74 M | 1.60% | 0.75% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 930.20 K | $27.01 M | 146.39% | 0.73% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/17/2026 | 914.02 K | $26.54 M | 9.66% | 0.72% |
| PERPETUAL LTD | 01/20/2026 | 910.63 K | $26.44 M | -55.02% | 0.71% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 02/13/2026 | 900.00 K | $26.14 M | 100.00% | 0.71% |
| FEDERATED HERMES, INC. | 02/12/2026 | 891.77 K | $25.90 M | 17.40% | 0.70% |
| OBERWEIS ASSET MANAGEMENT INC/ | 02/17/2026 | 808.40 K | $23.48 M | 100.00% | 0.63% |
| CANDRIAM S.C.A. | 04/30/2026 | 803.14 K | $23.32 M | 3.23% | 0.63% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 699.80 K | $20.32 M | 1,416.50% | 0.55% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 661.42 K | $19.21 M | -18.80% | 0.52% |
| NEARWATER CAPITAL MARKETS, LTD | 02/17/2026 | 615.00 K | $17.86 M | 100.00% | 0.48% |
| ABRDN PLC | 01/16/2026 | 586.40 K | $17.03 M | -13.13% | 0.46% |
| FISHMAN JAY A LTD/MI | 01/28/2026 | 564.65 K | $16.40 M | -0.18% | 0.44% |
| BIOIMPACT CAPITAL LLC | 02/17/2026 | 531.20 K | $15.43 M | 100.00% | 0.42% |
| BAMCO INC /NY/ | 02/17/2026 | 504.70 K | $14.66 M | 100.00% | 0.40% |
| CORMORANT ASSET MANAGEMENT, LP | 02/17/2026 | 500.00 K | $14.52 M | -35.48% | 0.39% |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | 02/17/2026 | 500.00 K | $14.52 M | 100.00% | 0.39% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 499.42 K | $14.50 M | 13.17% | 0.39% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 455.88 K | $13.24 M | 185.20% | 0.36% |
| MARSHALL WACE, LLP | 02/13/2026 | 454.23 K | $13.19 M | 2,382.15% | 0.36% |
| EVERSEPT PARTNERS, LP | 02/17/2026 | 434.63 K | $12.62 M | 289.93% | 0.34% |
| JUMP FINANCIAL, LLC | 02/17/2026 | 430.90 K | $12.51 M | 22.94% | 0.34% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 425.15 K | $12.35 M | 100.00% | 0.33% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 01/15/2026 | 418.04 K | $12.14 M | 100.00% | 0.33% |
| FIRST TRUST ADVISORS LP | 02/13/2026 | 404.65 K | $11.75 M | 79.87% | 0.32% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Arcutis Biotherapeutics Inc institutional Ownership - FAQ's
During the previous two years, 348 institutional investors and hedge funds held shares of Arcutis Biotherapeutics Inc. The most heavily invested institutionals were:
JENNISON ASSOCIATES LLC: 4.98 M
UBS Group AG: 3.33 M
Candriam S.C.A.: 1.09 M
FEDERATED HERMES, INC.: 1.08 M
Perpetual Ltd: 909,546
Nuveen, LLC: 902,134
101.15% of Arcutis Biotherapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 140.25 M shares in the last 24 months. This purchase volume represents approximately $3.48 B in transactions.